Could a smaller monkeypox vaccine dose still protect you?
NCT ID NCT05512949
First seen Apr 30, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study tested whether giving smaller doses of the MVA-BN monkeypox vaccine under the skin (instead of the usual larger dose under the fat) still triggers a strong immune response. About 229 healthy adults aged 18 to 50 received either the standard shot or one of two reduced doses. The goal was to see if using less vaccine per person could still protect against monkeypox, which could help stretch vaccine supplies during outbreaks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine
Houston, Texas, 77030-3411, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115-6110, United States
-
George Washington University Medical Faculty Associates
Washington D.C., District of Columbia, 20037, United States
-
NIH Clinical Research Center, Investigational Drug Management and Research Section
Bethesda, Maryland, 20892-1504, United States
-
Saint Louis University Center for Vaccine Development
St Louis, Missouri, 63104-1015, United States
-
The Hope Clinic of Emory University
Decatur, Georgia, 30030, United States
-
University of California, San Diego (UCSD) - Antiviral Research Center (AVRC)
San Diego, California, 92103-8208, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.